Partnering and scientific collaborations are key elements of CSP strategy as we continue to expand our portfolio of innovative products.
With our lead global ophthalmology asset CSP-270, CSP is actively seeking partners to support the additional development and commercialisation in major territories such as the USA, Europe and Japan.
For more information, please contact our VP of Business development: simon.bennett@cspharmaceuticals.com